Literature DB >> 189252

Skeletal muscle pseudohypertrophy in primary amyloidosis.

J N Whitaker, K Hashimoto, M Quinones.   

Abstract

Macroglossia and skeletal muscle enlargement with weakness appeared in a 38-year-old male who was shown to have amyloidosis and light chain multiple myeloma. Free lambda light chains were present in serum and urine. Skeletal muscle contained large amounts of amyloid and other amorphous material infiltrating blood vessel walls and connective tissue. Muscle fibers, particularly the type II variety, were diminished in size. Amyloid and similar amorphous material also were present in skin. This patient represents an unusual, but somewhat uniform, type of involvement of the neuromuscular apparatus in nonfamilial primary amyloidosis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 189252     DOI: 10.1212/wnl.27.1.47

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  7 in total

1.  In vitro myotrophic effect of serum kappa chain immunoglobulins from a patient with kappa light chain myeloma and muscular hypertrophy.

Authors:  C Delaporte; B Varet; M Fardeau; D Nochy; A Ract
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

2.  Amyloid associated muscle pseudohypertrophy: amelioration of motor dysfunction with plasmapheresis and dimethylsulphoxide.

Authors:  A Komiyama; M Kijima; M Takahashi; S Ishida; Y Ono
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-05       Impact factor: 10.154

3.  Early sarcolemmal dysfunction in skeletal muscle amyloidosis.

Authors:  C Doriguzzi; T Mongini; W Troni; G Monga
Journal:  J Neurol       Date:  1987-01       Impact factor: 4.849

4.  Proximal weakness of the extremities as main feature of amyloid myopathy.

Authors:  F G Jennekens; J H Wokke
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-10       Impact factor: 10.154

5.  Amyloid myopathy presenting with respiratory failure.

Authors:  J Ashe; C O Borel; G Hart; R L Humphrey; D A Derrick; R W Kuncl
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-02       Impact factor: 10.154

6.  Chronic myopathy due to immunoglobulin light chain amyloidosis.

Authors:  Irini Manoli; Justin Y Kwan; Qian Wang; Elisabeth J Rushing; Maria Tsokos; Andrew E Arai; Warner M Burch; Angela Dispenzieri; Alexandra C McPherron; William A Gahl
Journal:  Mol Genet Metab       Date:  2013-02-04       Impact factor: 4.797

7.  Generalized muscle pseudo-hypertrophy and stiffness associated with the myotilin Ser55Phe mutation: a novel myotilinopathy phenotype?

Authors:  Josep Gamez; Judith Armstrong; Alexey Shatunov; Albert Selva-O'Callaghan; Rosa Dominguez-Oronoz; Arantxa Ortega; Lev Goldfarb; Isidre Ferrer; Montse Olivé
Journal:  J Neurol Sci       Date:  2008-11-22       Impact factor: 3.181

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.